Curium Announces Ioflupane I 123 Injection Availability for Friday Patient Use

Curium Announces Ioflupane I 123 Injection Availability for Friday Patient Use

ST. LOUIS, Feb. 06, 2024 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear medicine, announced today that beginning Friday, April 5, 2024, Ioflupane I 123 Injection will be available for Friday patient administration in the US. This additional day of production allows customers to access the product and capitalize on early morning availability on … Read more

Rapala VMC Corporation: Operational plan proceeds – sells injection molding business

Rapala VMC Corporation: Operational plan proceeds – sells injection molding business

PRESS RELEASE, January 2, 2024 Rapala VMC Corporation has sold group’s entire injection molding business to a Finnish mold and injection molded parts manufacturer Muottituote Group Oy with an agreement signed on the December 22, 2023. With the transaction, Muottituote Group Oy acquires Rapala VMC Corporation’s subsidiary KL-Teho Oy’s real estate located in Korpilahti, Finland, … Read more